195 related articles for article (PubMed ID: 21969352)
1. Summaries for patients. The safety of magnetic resonance imaging in patients with pacemakers or defibrillators.
Ann Intern Med; 2011 Oct; 155(7):I34. PubMed ID: 21969352
[No Abstract] [Full Text] [Related]
2. Magnetic resonance imaging for patients with permanent pacemakers: initial clinical experience.
Goldsher D; Amikam S; Boulos M; Suleiman M; Shreiber R; Eran A; Goldshmid Y; Mazbar R; Roguin A
Isr Med Assoc J; 2006 Feb; 8(2):91-4. PubMed ID: 16544729
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging in patients with implantable cardioverter-defibrillators and pacemakers.
Roguin A
J Am Coll Cardiol; 2009 Aug; 54(6):556-7. PubMed ID: 19643319
[No Abstract] [Full Text] [Related]
4. Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry.
Russo RJ
Am Heart J; 2013 Mar; 165(3):266-72. PubMed ID: 23453091
[TBL] [Abstract][Full Text] [Related]
5. Cardiology Patient Page. Magnetic Resonance Imaging in Patients With Cardiac Implantable Electronic Devices.
Eyal A; Roguin A
Circulation; 2015 Oct; 132(14):e176-8. PubMed ID: 26438772
[No Abstract] [Full Text] [Related]
6. Magnetic resonance imaging in patients with implantable cardiac devices.
Sierra M; Machado C
Rev Cardiovasc Med; 2008; 9(4):232-8. PubMed ID: 19122581
[TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices.
Nazarian S; Hansford R; Roguin A; Goldsher D; Zviman MM; Lardo AC; Caffo BS; Frick KD; Kraut MA; Kamel IR; Calkins H; Berger RD; Bluemke DA; Halperin HR
Ann Intern Med; 2011 Oct; 155(7):415-24. PubMed ID: 21969340
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices.
Roguin A; Schwitter J; Vahlhaus C; Lombardi M; Brugada J; Vardas P; Auricchio A; Priori S; Sommer T
Europace; 2008 Mar; 10(3):336-46. PubMed ID: 18308754
[TBL] [Abstract][Full Text] [Related]
9. Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T.
Naehle CP; Kreuz J; Strach K; Schwab JO; Pingel S; Luechinger R; Fimmers R; Schild H; Thomas D
Am Heart J; 2011 Jun; 161(6):1096-105. PubMed ID: 21641356
[TBL] [Abstract][Full Text] [Related]
10. MRI in patients with cardiovascular implantable electronic devices.
Vieira MS; Lazoura O; Nicol E; Rubens M; Padley S
Clin Radiol; 2013 Sep; 68(9):928-34. PubMed ID: 23759137
[No Abstract] [Full Text] [Related]
11. MR in patients with pacemakers and ICDs: Defining the issues.
Shinbane JS; Colletti PM; Shellock FG
J Cardiovasc Magn Reson; 2007; 9(1):5-13. PubMed ID: 17178675
[TBL] [Abstract][Full Text] [Related]
12. Recent innovations in the development of magnetic resonance imaging conditional pacemakers and implantable cardioverter-defibrillators.
Lobodzinski SS
Cardiol J; 2012; 19(1):98-104. PubMed ID: 22298178
[TBL] [Abstract][Full Text] [Related]
13. [Safety of cardiac pacemakers and implantable cardioverter-defibrillators in magnetic resonance imaging. Assessment of the aggregate function at 1.5 tesla].
Nordbeck P; Bauer WR
Dtsch Med Wochenschr; 2008 Mar; 133(13):624-8. PubMed ID: 18351504
[TBL] [Abstract][Full Text] [Related]
14. Cardiac magnetic resonance imaging at 1.5 T in patients with cardiac rhythm devices.
Buendía F; Cano Ó; Sánchez-Gómez JM; Igual B; Osca J; Sancho-Tello MJ; Olagüe J; Salvador A
Europace; 2011 Apr; 13(4):533-8. PubMed ID: 21227955
[TBL] [Abstract][Full Text] [Related]
15. Follow-up. Pacemakers and MRIs.
Harv Heart Lett; 2006 Dec; 17(4):7. PubMed ID: 17297674
[No Abstract] [Full Text] [Related]
16. Reconsideration of pacemakers and MR imaging.
Loewy J; Loewy A; Kendall EJ
Radiographics; 2004; 24(5):1257-67; discussion 1267-8. PubMed ID: 15371606
[TBL] [Abstract][Full Text] [Related]
17. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
Cohen JD; Costa HS; Russo RJ
Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
[TBL] [Abstract][Full Text] [Related]
18. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
Ubee SS; Kasi VS; Bello D; Manikandan R
J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
[TBL] [Abstract][Full Text] [Related]
19. Pacemaker malfunction risks within the electromagnetically rich hospital environment.
Kakouros N; Kakouros SN
Hellenic J Cardiol; 2018; 59(4):247-248. PubMed ID: 29154816
[No Abstract] [Full Text] [Related]
20. Clarification to the article 'Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions'.
Mollerus ME
Europace; 2010 Dec; 12(12):1798. PubMed ID: 20710022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
